Corcept Therapeutics Incorporated Share Price

Corcept Therapeutics Incorporated Share Price

NASDAQ: CORT | Mid Cap
$70.06
+$0.84 (1.22%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Corcept Therapeutics Incorporated Stock Performance

Open
$69.69
Prev. Close
$69.22
Circuit Range
N/A
Day Range
$69.54 - $71.69
Year Range
$28.79 - $126.20
Volume
72,017
Average Traded
$70.43

Corcept Therapeutics Incorporated Share Price Today

As of 18 November 2026, Corcept Therapeutics Incorporated's share price is $70.06. The stock opened at $69.69, compared to its previous close of $69.22. During today's trading session, Corcept Therapeutics Incorporated's share price traded between $69.54 and $71.69, with an average price of $70.62. Over the past 52 weeks, the stock has recorded a high of $126.20 and a low of $28.79. In terms of performance, Corcept Therapeutics Incorporated's share price has risen by 0.89% over the last six months and is down 11.75% on a year-on-year basis.

Corcept Therapeutics Incorporated Share Price Chart

Line chart of the Corcept Therapeutics Incorporated price trend over the selected period. The price rose overall, ranging from 69.55 to 71.69, ending at 70.06.
$69.54$71.69
L
Show Current Price
H

Corcept Therapeutics Incorporated Stock Fundamentals & Key Indicators

Market Cap
$7.28B
PE Ratio (TTM)
46.21
Dividend Yield
0.00%
EPS (TTM)
$1.50
Revenue (TTM)
$761.41B
Return On Equity (TTM)
19.42%
Profit Margin
12.89%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
430.46%

Corcept Therapeutics Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$202.13$164.90$256.15$340.47
Net Profit$23.90-$31.76$42.99$126.78
Net Profit Margin11.82%-19.26%16.78%37.24%
Income ChangeN/A-232.89%235.36%194.91%

Corcept Therapeutics Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$401.86$482.38$675.04$761.41
Net Profit$101.29$105.50$139.73$98.17
Net Profit Margin25.21%21.87%20.70%12.89%
Income ChangeN/A4.16%32.45%-29.74%

About Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Corcept Therapeutics Incorporated Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$81.71
$70.08
-13.56%
Oct 2026
$113.88
$81.07
-29.75%
Sep 2026
$113.85
$115.41
-1.34%
Aug 2026
$114.58
$116.98
+2.19%
Jul 2026
$87.27
$114.47
+31.76%
Jun 2026
$69.20
$86.88
+25.11%
May 2026
$47.64
$69.44
+49.33%
Apr 2026
$40.63
$46.50
+15.37%
Mar 2026
$34.76
$40.30
+12.84%
Feb 2026
$41.12
$35.72
-10.30%
Jan 2026
$35.65
$39.82
+14.46%
Dec 2025
$78.00
$34.79
-56.18%

CORT Share Price FAQs